1h Free Analyst Time
The publisher has been monitoring the allergy immunotherapies market and it is poised to grow by $713.56 mn during 2021-2025, progressing at a CAGR of almost 8% during the forecast period. The report on allergy immunotherapies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of allergies, recent approvals and strong pipeline, and growing market consolidation.
The allergy immunotherapies market analysis includes product segment and geographic landscape.
The allergy immunotherapies market is segmented as below:
By Product
- SCIT
- SLIT
By Geography
- Europe
- North America
- Asia
- ROW
This study identifies the technological advances in allergy diagnostics as one of the prime reasons driving the allergy immunotherapies market growth during the next few years. Also, emerging drug development technologies and the growing popularity of slit will lead to sizable demand in the market.
The report on allergy immunotherapies market covers the following areas:
- Allergy immunotherapies market sizing
- Allergy immunotherapies market forecast
- Allergy immunotherapies market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading allergy immunotherapies market vendors that include Aimmune Therapeutics Inc., ALK-Abello AS, Allergy Therapeutics PLC, ASIT biotech, DBV Technologies SA, HAL Allergy BV, Jubilant Life Sciences Ltd., LETI Pharma SLU, Merck KGaA, and Stallergenes Greer Ltd. Also, the allergy immunotherapies market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Product
Customer landscape
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global allergy immunotherapies market: Aimmune Therapeutics Inc., ALK-Abello AS, Allergy Therapeutics PLC, ASIT biotech, DBV Technologies SA, HAL Allergy BV, Jubilant Life Sciences Ltd., LETI Pharma SLU, Merck KGaA, and Stallergenes Greer Ltd.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is the technological advances in allergy diagnostics.'
According to the report, one of the major drivers for this market is the increasing prevalence of allergies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aimmune Therapeutics Inc.
- ALK-Abello AS
- Allergy Therapeutics PLC
- ASIT biotech
- DBV Technologies SA
- HAL Allergy BV
- Jubilant Life Sciences Ltd.
- LETI Pharma SLU
- Merck KGaA
- Stallergenes Greer Ltd.